Lakefront Biotherapeutics (LKFT) Times Interest Earned (2016 - 2020)

Lakefront Biotherapeutics (LKFT) has 5 years of Times Interest Earned data on file, last reported at -$45.88 in Q1 2020.

• Times Interest Earned for Q1 2020 came in at -$45.88, up 79.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $958314895.6 billion (up 329.45% YoY), and the FY2025 annual result was $285.34, up 238.02% from the prior year.
• Times Interest Earned declined to -$45.88 in Q1 2020 per LKFT's latest filing, from -$42.51 in the prior quarter.
• Over five years, Times Interest Earned peaked at $108.72 in Q3 2019 and troughed at -$224.65 in Q1 2019.
• A 5-year average of -$23.01 and a median of -$0.65 in 2016 frame the typical range for Times Interest Earned.
• On a YoY basis, Times Interest Earned climbed as much as 3280.07% in 2018 and fell as far as 4592.28% in 2018.
• A 5-year view of Times Interest Earned shows it stood at -$0.33 in 2016, then tumbled by 201.24% to -$0.98 in 2017, then surged by 3280.07% to $31.24 in 2018, then plunged by 236.08% to -$42.51 in 2019, then slipped by 7.93% to -$45.88 in 2020.
• Business Quant data shows LKFT's Times Interest Earned at -$45.88 in Q1 2020, -$42.51 in Q4 2019, and $108.72 in Q3 2019.